GCG and myocardial infarction: When Bead-GLP-1 MSCs were delivered to coronary artery branches in a porcine MI model, the echocardiography results showed improved left ventricular (LV) function, whereas histological analysis showed reduced inflammation and a lower apoptosis rate, indicating that combining the therapeutic strategies of utilizing recombinant GLP-1 and the inherent paracrine stem cell factors of MSCs might be beneficial for clinical application against MI.